Galectin Therapeutics (GALT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research on MSN
Here's why Genpact (G) is a strong value stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Zacks Investment Research on MSN
Here's why Viking Holdings (VIK) is a strong momentum stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Detailed price information for Costco Wholesale (COST-Q) from The Globe and Mail including charting and trades.
Joe Zacks, Co Founder and Managing Director of Aardwolf Global Solutions and former CIA intelligence officer, warns tensions with Iran could escalate into limited strikes without ground troops, with ...
Spread the loveAs the financial markets continue to evolve, savvy investors are always on the lookout for stocks that not only promise growth but also have the potential to outperform earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results